Segment disclosures

Company overview

엔케이젠바이오텍코리아

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 49 retained observations 33 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-302138035746 KRW20260930Open filing evidence
2026-01-01 – 2026-06-303712679876 KRW20260930Open filing evidence
2026-01-01 – 2026-03-311574644130 KRW20260515Open filing evidence
2025-01-01 – 2025-12-317862515138 KRW20260324Open filing evidence
2025-07-01 – 2025-09-302205602717 KRW20251204Open filing evidence
2025-01-01 – 2025-09-305651915865 KRW20251204Open filing evidence
2025-04-01 – 2025-06-302021139646 KRW20260930Open filing evidence
2025-01-01 – 2025-06-303446313148 KRW20260930Open filing evidence
2025-01-01 – 2025-03-311423402177 KRW20260515Open filing evidence
2024-01-01 – 2024-12-318800038505 KRW20260324Open filing evidence
2024-07-01 – 2024-09-302332227493 RestatedKRW20251204Open filing evidence
2024-01-01 – 2024-09-306572315407 RestatedKRW20251204Open filing evidence
2024-04-01 – 2024-06-302436476592 RestatedKRW20250814Open filing evidence
2024-01-01 – 2024-06-304240087914 KRW20250814Open filing evidence
2024-01-01 – 2024-03-311813321946 KRW20250515Open filing evidence
2023-01-01 – 2023-12-319947882202 RestatedKRW20260324Open filing evidence
2023-07-01 – 2023-09-302681419717 KRW20241114Open filing evidence
2023-01-01 – 2023-09-307485598172 KRW20241114Open filing evidence
2023-04-01 – 2023-06-302696512829 KRW20240814Open filing evidence
2023-01-01 – 2023-06-304804178455 KRW20240814Open filing evidence
2023-01-01 – 2023-03-312107665626 KRW20240516Open filing evidence
2022-01-01 – 2022-12-3111262689377 KRW20250812Open filing evidence
2022-07-01 – 2022-09-302734034477 KRW20231114Open filing evidence
2022-01-01 – 2022-09-307803425791 KRW20231114Open filing evidence
2022-04-01 – 2022-06-302427253332 KRW20231114Open filing evidence
2022-01-01 – 2022-06-305069391314 KRW20231114Open filing evidence
2022-01-01 – 2022-03-312642137982 KRW20230515Open filing evidence
2021-01-01 – 2021-12-3113020252251 KRW20240411Open filing evidence
2021-07-01 – 2021-09-303188590140 KRW20221114Open filing evidence
2021-01-01 – 2021-09-309119042141 KRW20221114Open filing evidence
2021-04-01 – 2021-06-303039036295 KRW20220816Open filing evidence
2021-01-01 – 2021-06-305930452001 KRW20220816Open filing evidence
2021-01-01 – 2021-03-312891415706 KRW20220516Open filing evidence
2020-01-01 – 2020-12-3110371545183 KRW20230320Open filing evidence
2020-07-01 – 2020-09-302542592199 KRW20211115Open filing evidence
2020-01-01 – 2020-09-306885663537 KRW20211115Open filing evidence
2020-04-01 – 2020-06-302314454269 KRW20210817Open filing evidence
2020-01-01 – 2020-06-304343071338 KRW20210817Open filing evidence
2020-01-01 – 2020-03-312028617069 KRW20210712Open filing evidence
2019-01-01 – 2019-12-318749217674 KRW20220506Open filing evidence
2019-07-01 – 2019-09-302296018455 KRW20201113Open filing evidence
2019-01-01 – 2019-09-306218925349 KRW20201113Open filing evidence
2019-04-01 – 2019-06-301866830110 KRW20200814Open filing evidence
2019-01-01 – 2019-06-303922906894 KRW20200814Open filing evidence
2019-01-01 – 2019-03-312056076784 KRW20200515Open filing evidence
2018-01-01 – 2018-12-316268827447 KRW20210712Open filing evidence
2018-07-01 – 2018-09-301555673910 KRW20191114Open filing evidence
2018-01-01 – 2018-09-304662437842 KRW20191114Open filing evidence
2017-01-01 – 2017-12-314829585004 KRW20200330Open filing evidence